Home » Newsletters » BioWorld

BioWorld

Jan. 19, 1993

View Archived Issues

GENSIA APPLIES TO MARKET ARASINE IN EUROPE

MYCOGEN DEAL WITH FORAGE GENETICS

GI LICENSES FACTOR IX PROTEIN

CYTOGEN SHIPS ONCOSCINT

CANGUARD PACT WITH ATHENA

CHIRON ESTABLISHES MARKETER

AIS LICENSES ANTI-CD34 ANTIBODIES

APPLIED BIOSCIENCE CONSOLIDATES COMPANIES

PHOTODYNAMIC SKIN TUMOR TREATMENT 'EFFECTIVE'

GLAXO EXPANDS STAKE IN BIOCHEM PHARMA

VESTAR DONATES DRUG TO KS PATIENTS

SUGEN JOINS FORCES WITH SELECTIDE

CENTOCOR HALTS TRIALS; STOCK PLUMMETS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...